Trial Profile
A phase 1b randomized, open, positive control clinical trial to evaluate tolerability, pharmacokinetics and pharmacodynamics of muti-dose of HS-10234 in HBV-infected subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Dec 2020
Price :
$35
*
At a glance
- Drugs Tenofovir amibufenamide (Primary) ; Tenofovir disoproxil fumarate
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Shanghai Hansen Biomedical Technology
- 28 Nov 2020 Status changed from recruiting to completed as per results published in the Alimentary Pharmacology and Therapeutics.
- 28 Nov 2020 Results published in the Alimentary Pharmacology and Therapeutics
- 25 Apr 2017 New trial record